Pricing
Login
Home
Charts
Search
Watchlist
Products

Sun Pharma Advanced Research Company Ltd

SPARC
₹190.16-1.25%20 Nov 2026
Reports
Pharma Others

Sun Pharma Advanced Research Company Ltd

SPARC
₹190.16
-1.25%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹6,171Cr
Close
Close Price
₹190.16
Industry
Industry
Pharma Others
PE
Price To Earnings
3.77
PS
Price To Sales
3.19
Revenue
Revenue
₹1,932Cr
Rev Gr TTM
Revenue Growth TTM
3,140.97%
PAT Gr TTM
PAT Growth TTM
712.64%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
14171713152710881,8534030
Growth YoY
Revenue Growth YoY%
-65.3-29.8-39.37.664.2-42.6-38.9-43.36,715.8314.1282.1
Expenses
ExpensesCr
1161221101168980627465807476
Operating Profit
Operating ProfitCr
-103-106-93-103-74-53-52-66-571,773-34-46
OPM
OPM%
-740.4-639.1-555.4-800.2-494.2-195.6-540.3-836.1-670.395.7-85.2-151.9
Other Income
Other IncomeCr
64200090-1222424
Interest Expense
Interest ExpenseCr
0111356891280
Depreciation
DepreciationCr
333333333222
PBT
PBTCr
-100-105-96-107-79-61-52-76-801,761-21-24
Tax
TaxCr
00000-1000000
PAT
PATCr
-100-106-96-107-80-60-52-76-801,761-21-24
Growth YoY
PAT Growth YoY%
-29.0-0.6-24.220.243.545.929.3-1.13,046.959.967.8
NPM
NPM%
-719.0-638.8-570.5-834.6-533.3-219.8-538.1-965.0-951.795.0-52.0-81.2
EPS
EPS₹
-3.1-3.3-3.0-3.3-2.5-1.8-1.6-2.3-2.554.3-0.6-0.8
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
14171713152710881,8534030
Growth YoY
Revenue Growth YoY%
-65.3-29.8-39.37.664.2-42.6-38.9-43.36,715.8314.1282.1
Expenses
ExpensesCr
1161221101168980627465807476
Operating Profit
Operating ProfitCr
-103-106-93-103-74-53-52-66-571,773-34-46
OPM
OPM%
-740.4-639.1-555.4-800.2-494.2-195.6-540.3-836.1-670.395.7-85.2-151.9
Other Income
Other IncomeCr
64200090-1222424
Interest Expense
Interest ExpenseCr
0111356891280
Depreciation
DepreciationCr
333333333222
PBT
PBTCr
-100-105-96-107-79-61-52-76-801,761-21-24
Tax
TaxCr
00000-1000000
PAT
PATCr
-100-106-96-107-80-60-52-76-801,761-21-24
Growth YoY
PAT Growth YoY%
-29.0-0.6-24.220.243.545.929.3-1.13,046.959.967.8
NPM
NPM%
-719.0-638.8-570.5-834.6-533.3-219.8-538.1-965.0-951.795.0-52.0-81.2
EPS
EPS₹
-3.1-3.3-3.0-3.3-2.5-1.8-1.6-2.3-2.554.3-0.6-0.8

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
23976721,8791,932
Growth
Revenue Growth%
-68.4-5.02,518.53,141.0
Expenses
ExpensesCr
453478395280295
Operating Profit
Operating ProfitCr
-214-402-3231,5991,637
OPM
OPM%
-89.7-532.3-450.385.184.7
Other Income
Other IncomeCr
11292-137
Interest Expense
Interest ExpenseCr
8293429
Depreciation
DepreciationCr
121312109
PBT
PBTCr
-223-387-3431,5531,636
Tax
TaxCr
00000
PAT
PATCr
-223-387-3431,5531,636
Growth
PAT Growth%
-74.011.6553.5712.6
NPM
NPM%
-93.2-512.6-477.382.784.7
EPS
EPS₹
-7.8-11.9-10.647.950.4
Financial YearMar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
23976721,8791,932
Growth
Revenue Growth%
-68.4-5.02,518.53,141.0
Expenses
ExpensesCr
453478395280295
Operating Profit
Operating ProfitCr
-214-402-3231,5991,637
OPM
OPM%
-89.7-532.3-450.385.184.7
Other Income
Other IncomeCr
11292-137
Interest Expense
Interest ExpenseCr
8293429
Depreciation
DepreciationCr
121312109
PBT
PBTCr
-223-387-3431,5531,636
Tax
TaxCr
00000
PAT
PATCr
-223-387-3431,5531,636
Growth
PAT Growth%
-74.011.6553.5712.6
NPM
NPM%
-93.2-512.6-477.382.784.7
EPS
EPS₹
-7.8-11.9-10.647.950.4
Sales CAGR
1 Year2518%
3 Years99%
5 Years-
TTM3141%
Avg. ROCE
1 Year84%
3 Years-255%
5 Years-
TTM115%
CFO / EBITDA
1 Year-15%
3 Years-118%
5 Years-
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
3232323232
Reserves
ReservesCr
48093-2491,3061,410
Current Liabilities
Current LiabilitiesCr
179265374754182
Non Current Liabilities
Non Current LiabilitiesCr
1381241787850
Total Liabilities
Total LiabilitiesCr
8305153362,1711,674
Current Assets
Current AssetsCr
455269261,8621,390
Non Current Assets
Non Current AssetsCr
375246309308283
Total Assets
Total AssetsCr
8305153362,1711,674
Financial YearMar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
3232323232
Reserves
ReservesCr
48093-2491,3061,410
Current Liabilities
Current LiabilitiesCr
179265374754182
Non Current Liabilities
Non Current LiabilitiesCr
1381241787850
Total Liabilities
Total LiabilitiesCr
8305153362,1711,674
Current Assets
Current AssetsCr
455269261,8621,390
Non Current Assets
Non Current AssetsCr
375246309308283
Total Assets
Total AssetsCr
8305153362,1711,674

Cash Flow

Consolidated
Standalone
Financial YearMar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-69-429-360-239
Investing Cash Flow
Investing Cash FlowCr
-548392158-24
Financing Cash Flow
Financing Cash FlowCr
61742199261
Net Cash Flow
Net Cash FlowCr
-15-3-1
Free Cash Flow
Free Cash FlowCr
-84-455-370-262
CFO To PAT
CFO To PAT%
31.1110.8105.2-15.4
CFO To EBITDA
CFO To EBITDA%
32.3106.7111.5-14.9
Financial YearMar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-69-429-360-239
Investing Cash Flow
Investing Cash FlowCr
-548392158-24
Financing Cash Flow
Financing Cash FlowCr
61742199261
Net Cash Flow
Net Cash FlowCr
-15-3-1
Free Cash Flow
Free Cash FlowCr
-84-455-370-262
CFO To PAT
CFO To PAT%
31.1110.8105.2-15.4
CFO To EBITDA
CFO To EBITDA%
32.3106.7111.5-14.9

Ratios

Consolidated
Standalone
Financial YearMar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5,82412,0064,8033,7196,171
Price To Earnings
Price To Earnings
2.43.8
Price To Sales
Price To Sales
24.4158.966.92.03.2
Price To Book
Price To Book
11.495.3-22.22.84.3
EV To EBITDA
EV To EBITDA
-26.8-29.6-15.72.73.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
84.136.740.297.897.8
OPM
OPM%
-89.7-532.3-450.385.184.7
NPM
NPM%
-93.2-512.6-477.382.784.7
ROCE
ROCE%
-40.7-206.1-642.083.6115.4
ROE
ROE%
-43.4-307.9157.9116.0113.4
ROA
ROA%
-26.8-75.2-102.171.597.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5,82412,0064,8033,7196,171
Price To Earnings
Price To Earnings
2.43.8
Price To Sales
Price To Sales
24.4158.966.92.03.2
Price To Book
Price To Book
11.495.3-22.22.84.3
EV To EBITDA
EV To EBITDA
-26.8-29.6-15.72.73.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
84.136.740.297.897.8
OPM
OPM%
-89.7-532.3-450.385.184.7
NPM
NPM%
-93.2-512.6-477.382.784.7
ROCE
ROCE%
-40.7-206.1-642.083.6115.4
ROE
ROE%
-43.4-307.9157.9116.0113.4
ROA
ROA%
-26.8-75.2-102.171.597.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr6,1713,7243,3022,0592,0581,569963
Close PriceClose₹190.1684.16468.9521.90335.951,110.15817.60
IndustryIndustryPharma OthersPharma OthersPharma OthersPharma OthersPharma OthersPharma OthersPharma Others
Price To EarningsPE3.7782.519.7421.68111.615.6719.57
Price To SalesPS3.1932.911.393.972.851.710.90
RevenueRevenueCr1,9321132,3695187219181,068
Revenue Growth TTMRev Gr TTM%3,141.0%222.2%6.4%0.6%19.4%11.3%42.7%
PAT Growth TTMPAT Gr TTM%712.6%270.5%283.1%51.6%323.7%317.3%16.8%
Market CapitalizationMkt CapCr6,1713,7243,3022,0592,0581,569963
Close PriceClose₹190.1684.16468.9521.90335.951,110.15817.60
IndustryIndustryPharma OthersPharma OthersPharma OthersPharma OthersPharma OthersPharma OthersPharma Others
Price To EarningsPE3.7782.519.7421.68111.615.6719.57
Price To SalesPS3.1932.911.393.972.851.710.90
RevenueRevenueCr1,9321132,3695187219181,068
Revenue Growth TTMRev Gr TTM%3,141.0%222.2%6.4%0.6%19.4%11.3%42.7%
PAT Growth TTMPAT Gr TTM%712.6%270.5%283.1%51.6%323.7%317.3%16.8%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
ResultPPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
ResultPPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
ResultPPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
ResultPPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
ResultPPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
ResultPPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
ResultPPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
ResultPPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
ResultPPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
ResultPPT
Transcript
Summary
Load More
Interviews